Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genenta Science SpA Sponsored ADR (GNTA)
NASDAQ:GNTA
RESEARCH TOOLSreports
Holding GNTA?
Track your performance easily
GNTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.20 - $7.28
Previous Close$4.69
Volume8.41K
Average Volume (3M)14.21K
Market Cap
$85.85M
Enterprise Value$65.95M
Total Cash (Recent Filing)€18.78M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.90
Next Earnings
Apr 26, 2023EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding18,216,958
10 Day Avg. Volume6,414
30 Day Avg. Volume14,213
Standard Deviation0.16
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$23.00Price Target Upside389.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Genenta Science SpA Sponsored ADR News
PremiumCompany Announcements
Genenta Science Advances Biotech Endeavors
PremiumCompany Announcements
Genenta Science Announces ADS Sales Agreement
PremiumCompany Announcements
Genenta Science Announces Board RestructuringOwnership Overview
12.60%
Insiders
1.35% Other Institutional Investors
86.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GNTA FAQ
What was Genenta Science SpA Sponsored ADR’s price range in the past 12 months?
Genenta Science SpA Sponsored ADR lowest stock price was $2.20 and its highest was $7.28 in the past 12 months.
What is Genenta Science SpA Sponsored ADR’s market cap?
Currently, no data Available
When is Genenta Science SpA Sponsored ADR’s upcoming earnings report date?
Genenta Science SpA Sponsored ADR’s upcoming earnings report date is Apr 26, 2023 which is 579 days ago.
How were Genenta Science SpA Sponsored ADR’s earnings last quarter?
Genenta Science SpA Sponsored ADR released its earnings results on Oct 24, 2022. The company reported -$0.127 earnings per share for the quarter, beating the consensus estimate of -$0.159 by $0.032.
Is Genenta Science SpA Sponsored ADR overvalued?
According to Wall Street analysts Genenta Science SpA Sponsored ADR’s price is currently Undervalued.
Does Genenta Science SpA Sponsored ADR pay dividends?
Genenta Science SpA Sponsored ADR does not currently pay dividends.
What is Genenta Science SpA Sponsored ADR’s EPS estimate?
Genenta Science SpA Sponsored ADR’s EPS estimate is -$0.37.
How many shares outstanding does Genenta Science SpA Sponsored ADR have?
Genenta Science SpA Sponsored ADR has 18,216,957 shares outstanding.
What happened to Genenta Science SpA Sponsored ADR’s price movement after its last earnings report?
Genenta Science SpA Sponsored ADR reported an EPS of -$0.127 in its last earnings report, beating expectations of -$0.159. Following the earnings report the stock price went down -3.226%.
Which hedge fund is a major shareholder of Genenta Science SpA Sponsored ADR?
Currently, no hedge funds are holding shares in GNTA
---
Genenta Science SpA Sponsored ADR Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.56%
12-Months-Change
Fundamentals
Return on Equity
-42.81%
Trailing 12-Months
Asset Growth
-30.10%
Trailing 12-Months
Company Description
Genenta Science SpA Sponsored ADR
Genenta Science SPA is a clinical-stage biotechnology company pioneering the development of lentivirus-based first-in-class gene and cell therapies in cancer.
---
GNTA Stock 12 Month Forecast
Average Price Target
$23.00
▲(389.99% Upside)
Technical Analysis
Alaunos Therapeutics
―
Oncternal Therapeutics
―
Cellectar Biosciences
―
Adaptimmune Therapeutics
―
Best Analysts Covering GNTA
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+19.75%
reiterated a buy rating 2 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +19.75% per trade.
---